siRNA, Anti-MTRNR2L4, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT71522WQ-2OMe)

The product SIRGT71522WQ-2OMe is a type of small interfering RNA (siRNA) that targets MTRNR2L4 gene and regulates the expression of gene. The siRNA interferes with the expression of MTRNR2L4 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001190476.1
Alternative Names HN4
Related Diseases Oculomotor Nerve Paralysis
Purification HPLC
Target Gene
Gene ID 100463285
Uniprot ID P0CJ71
Sub Cat Target Species Modification Scale  
SIRGT72522WQ-2F MTRNR2L4 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT73522WQ-2MOE MTRNR2L4 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT74522WQ-LNA MTRNR2L4 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT71522WQ-RB MTRNR2L4 Human Ribo-modified Inquiry
SIRGT72522WQ-BB MTRNR2L4 Human Backbone-modified Inquiry

Related Products